Foundayo
RxNorm concept 2739845, brand name (bn).
- RxCUI
- 2739845
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2739845 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- orforglipron 0.8 MG [Foundayo] (SBDC, ingredient of)
- Foundayo Oral Product (SBDG, ingredient of)
- Foundayo Pill (SBDG, ingredient of)
- orforglipron Oral Tablet [Foundayo] (SBDF, ingredient of)
- orforglipron 0.8 MG Oral Tablet [Foundayo] (SBD, ingredient of)
- orforglipron 2.5 MG [Foundayo] (SBDC, ingredient of)
- orforglipron 2.5 MG Oral Tablet [Foundayo] (SBD, ingredient of)
- orforglipron 5.5 MG [Foundayo] (SBDC, ingredient of)
- orforglipron 5.5 MG Oral Tablet [Foundayo] (SBD, ingredient of)
- orforglipron 9 MG [Foundayo] (SBDC, ingredient of)
- orforglipron 9 MG Oral Tablet [Foundayo] (SBD, ingredient of)
- orforglipron 14.5 MG [Foundayo] (SBDC, ingredient of)
- orforglipron 14.5 MG Oral Tablet [Foundayo] (SBD, ingredient of)
- orforglipron 17.2 MG [Foundayo] (SBDC, ingredient of)
- orforglipron 17.2 MG Oral Tablet [Foundayo] (SBD, ingredient of)
- orforglipron (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2739845 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2739845 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2739845. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.